You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

HEPARIN LOCK FLUSH Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Heparin Lock Flush patents expire, and when can generic versions of Heparin Lock Flush launch?

Heparin Lock Flush is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, and Solopak. and is included in seventeen NDAs.

The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin Lock Flush

A generic version of HEPARIN LOCK FLUSH was approved as heparin sodium by HOSPIRA on April 28th, 1983.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HEPARIN LOCK FLUSH?
  • What are the global sales for HEPARIN LOCK FLUSH?
  • What is Average Wholesale Price for HEPARIN LOCK FLUSH?
Summary for HEPARIN LOCK FLUSH
US Patents:0
Applicants:6
NDAs:17
Clinical Trials: 1,022
DailyMed Link:HEPARIN LOCK FLUSH at DailyMed
Drug patent expirations by year for HEPARIN LOCK FLUSH
Recent Clinical Trials for HEPARIN LOCK FLUSH

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, AngersPhase 3
Fertility Center of Las VegasPhase 4
Sydney Local Health DistrictPhase 2

See all HEPARIN LOCK FLUSH clinical trials

US Patents and Regulatory Information for HEPARIN LOCK FLUSH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 005264-010 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Solopak HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 088459-001 Jul 26, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Smith And Nephew HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 087904-001 Apr 20, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.